12
Participants
Start Date
August 31, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
February 28, 2025
NTQ5082 capsule
"Part 1:The subjects are orally administered NT5082 capsules on an empty stomach in the first cycle and after a meal in the second cycle.~Part 2:The subjects are orally administered NT5082 capsules after a meal in the first cycle and on an empty stomach in the second cycle."
The Third hospital of Changsha, Changsha
Lead Sponsor
Nanjing Chia-tai Tianqing Pharmaceutical
INDUSTRY